Prosperity Consulting Group LLC Has $3.56 Million Position in Relx Plc (NYSE:RELX)

Prosperity Consulting Group LLC cut its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 5.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,468 shares of the technology company's stock after selling 4,819 shares during the period. Prosperity Consulting Group LLC's holdings in Relx were worth $3,564,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in RELX. Private Trust Co. NA increased its stake in shares of Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares during the period. Sage Mountain Advisors LLC raised its stake in shares of Relx by 5.1% in the 4th quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after buying an additional 258 shares in the last quarter. DRW Securities LLC raised its stake in shares of Relx by 5.9% in the 4th quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock worth $211,000 after buying an additional 259 shares in the last quarter. Peapack Gladstone Financial Corp boosted its stake in Relx by 5.7% during the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock valued at $234,000 after buying an additional 267 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC grew its holdings in Relx by 3.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after acquiring an additional 267 shares during the period. 15.02% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on RELX. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Redburn Atlantic assumed coverage on Relx in a report on Wednesday, January 8th. They issued a "buy" rating on the stock. The Goldman Sachs Group assumed coverage on Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Relx has an average rating of "Buy".

Relx Stock Down 0.9 %

NYSE:RELX traded down $0.51 during trading hours on Thursday, hitting $54.13. 485,469 shares of the stock traded hands, compared to its average volume of 708,287. The firm has a 50 day moving average price of $49.77 and a 200 day moving average price of $48.37. The firm has a market cap of $100.17 billion, a price-to-earnings ratio of 29.10, a PEG ratio of 2.73 and a beta of 0.84. Relx Plc has a fifty-two week low of $40.77 and a fifty-two week high of $55.21. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. This represents a yield of 1.6%. This is a positive change from Relx's previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. Relx's payout ratio is presently 59.68%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.